Product image of Minoksidil Norfri (Minoxidil) supplied by GNH India

Minoksidil Norfri

Active Ingredient:
Minoxidil
Origin:
EU

Minoksidil Norfri (Minoxidil)

Minoxidil, the active ingredient in Minoksidil Norfri, is a potassium channel opener presented as a topical solution for topical use. It promotes hair regrowth in individuals with androgenetic alopecia. The drug acts locally on the scalp, enhancing follicular size and prolonging the growth phase of hair.

GNH India supplies Minoksidil Norfri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to continual stringent quality standards and provides efficient reliable logistics for global distribution.

Manufacturer / TM Owner

Evolan Pharma Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minoksidil Norfri (minoxidil) is used to address hair loss conditions within the androgenetic alopecia spectrum.

  • Male pattern hair loss: stimulates regrowth of thinning scalp hair in men.
  • Female pattern hair loss: supports hair density improvement in women with androgenetic alopecia.
  • General androgenetic alopecia: promotes follicular activity and prolongs the anagen phase of hair growth.

How It Works

  • Minoxidil acts as a potassium channel opener that binds to ATP‑sensitive potassium channels in dermal papilla cells. This causes hyperpolarization of cell membranes, leading to vasodilation of scalp micro‑vasculature and increased blood flow. The enhanced perfusion supplies nutrients and oxygen to hair follicles, while the cellular signaling cascade prolongs the anagen (growth) phase, resulting in thicker, longer hair shafts.

Side Effects

Topical minoxidil may cause a range of local and systemic reactions.

Common Side Effects

  • Scalp itching: mild irritation at the application site.
  • Dryness or flaking: reduced scalp moisture.
  • Redness: mild erythema.
  • Unwanted facial hair growth: hypertrichosis in adjacent areas.
  • Dermatitis: contact skin inflammation.
  • Burning sensation: transient discomfort after application.

Serious or Rare Side Effects

  • Severe contact dermatitis: intense skin reaction requiring medical attention.
  • Chest pain: possible cardiovascular symptom.
  • Rapid heart rate: tachycardia.
  • Low blood pressure: hypotension.
  • Dizziness or fainting: syncope.
  • Swelling of hands or feet: peripheral edema.

Precautions & Warnings

Before using Minoksidil Norfri, consider the following precautions to ensure safe and effective treatment.

  • Cardiovascular assessment: evaluate blood pressure and heart condition prior to use.
  • Scalp condition: avoid application on irritated, infected or wounded skin.
  • Age restriction: not recommended for children under 18 years.
  • Concomitant irritants: do not combine with other topical hair products that may increase irritation.
  • Pregnancy and lactation: consult a healthcare professional before use.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Minoksidil Norfri can interact with other medications; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid)

  • Oral antihypertensives: additive blood‑pressure lowering effect may cause hypotension.
  • Other vasodilators: combined use can lead to excessive vasodilation and dizziness.
  • Systemic potassium channel openers: may amplify cardiovascular effects.

Moderate Interactions (Monitor Closely)

  • Topical corticosteroids: may increase skin irritation when used together.
  • Hair dyes or chemical treatments: could alter drug absorption.
  • Beta‑blockers: monitor heart rate and blood pressure.
  • NSAIDs: watch for potential fluid retention.
  • Herbal supplements (e.g., ginkgo): observe for blood‑pressure changes.

Frequently Asked Questions

Minoksidil Norfri contains minoxidil, a topical agent indicated for the treatment of androgenetic alopecia in both men and women. It is applied to the scalp to stimulate hair follicles, increase hair density, and slow further hair loss.

Minoxidil opens ATP‑sensitive potassium channels in dermal papilla cells, causing vasodilation and improved blood flow to the scalp. This enhances nutrient delivery to hair follicles and extends the anagen (growth) phase, resulting in thicker and longer hairs.

The appropriate dose and frequency are determined by a qualified healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical minoxidil in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using the product.

To request Minoksidil Norfri, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minoxidil is the only FDA‑approved topical potassium channel opener for androgenetic alopecia. Compared with oral finasteride, which works systemically by inhibiting DHT, minoxidil acts locally on the scalp and is suitable for both men and women, though results may vary and combination therapy is sometimes considered.

Store the product at room temperature, below 25 °C, in its original container. Keep it away from direct sunlight, moisture and heat sources. Ensure the cap is tightly closed to maintain stability.

Apply the recommended amount of the topical solution to a clean, dry scalp area twice daily, or as directed by the prescriber. Use the supplied dropper or applicator, massage gently, and allow the product to dry before styling or using other hair products.

Serious adverse events are rare but may include severe contact dermatitis, chest pain, rapid heart rate, low blood pressure, dizziness, or swelling of the extremities. If any of these occur, discontinue use and seek medical attention promptly.

Individuals with known hypersensitivity to minoxidil or any formulation component should avoid the product. It is also not recommended for children under 18 years, for people with severe scalp conditions (e.g., infections, wounds), or for those with uncontrolled cardiovascular disease without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minoxidil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT